 On Wednesday, July 29, Conmed NYSE: CNMD will report its last quarters earnings. Here is Benzingas preview of the companys release.Earnings and Revenue Wall Street analysts see Conmed reporting a loss of 0.98 per share on revenue of 124.92 million. Conmed earnings in the same period a year ago was 0.560 per share. Quarterly sales came in at 238.26 million. The analyst consensus estimate would represent a 275.0 decrease in the companys earnings. Revenue would be down 43.66 from the same quarter last year. Heres how the companys EPS has stacked up against analyst estimates in the past:Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019 EPS Estimate 0.54 0.89 0.56 0.53 EPS Actual 0.51 0.90 0.62 0.56 Revenue Estimate 221.71 M 265.57 M 227.93 M 233.26 M Revenue Actual 214.01 M 264.87 M 233.59 M 238.26 M Stock Performance Shares of Conmed were trading at 84.65 as of July 28. Over the last 52-week period, shares are down 3.96. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.View more earnings on CNMDConsidering these returns, shareholders will likely be feeling unsatisfied going into this earnings release.Dont be surprised to see the stock move on comments made during its conference call. Conmed is scheduled to hold the call at 16:30:00 ET and can be accessed here: more from Benzinga A Look Into Pfizers Price Over Earnings Stocks That Hit 52-Week Highs On Tuesday Martin Marietta Materials: Q2 Earnings InsightsC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 